Rare and Genetic Kidney Disease Drug Development Summit
Evvnt Promotion / evvnt
Archiv

30.11.2021 - 02.12.2021 Online
Time: 10:00 am - 5:30 pm
Kongressthemen
Marrying unmissable insights from global renal experts, the 1st Rare and Genetic Kidney Disease Drug Development Summit is uniquely positioned to provide you with transformative perspectives from identifying genetic drivers of rare kidney diseases to innovative trial design in small disease populations to accelerate progress of your genetic kidney disease pipeline.
Marrying unmissable insights from global renal experts, the 1st Rare and Genetic Kidney Disease Drug Development Summit is uniquely positioned to provide you with transformative perspectives from identifying genetic drivers of rare kidney diseases to innovative trial design in small disease populations to accelerate progress of your genetic kidney disease pipeline.
Kongressorganizer (PCO)
Hanson Wade
Hanson Wade
Anmerkungen
Brochure: https://go.evvnt.com/853526-3?pid=4832
Speakers: Alan Glicklich, Chief Medical Officer, Chinook Therapeutics, Alex Bell, Director Kidney Disease Drug Discovery, Ionis Pharmaceuticals and more
Brochure: https://go.evvnt.com/853526-3?pid=4832
Speakers: Alan Glicklich, Chief Medical Officer, Chinook Therapeutics, Alex Bell, Director Kidney Disease Drug Discovery, Ionis Pharmaceuticals and more
Anfragen und Anmeldung:
https://go.evvnt.com/853526-1?pid=4832
Frau Emily Birt
Allgemeinmedizin
Sprache
Englisch
Englisch
Kongressgebühr
USD 1899.00 - USD 3397.00
USD 1899.00 - USD 3397.00
Teilnehmer erwartet
1000
1000
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
83 Great Titchfield Street
W1W 6RH London
Großbritannien
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."